Literature DB >> 6204941

Distribution of alpha 2-macroglobulin in normal, inflammatory, and tumor tissues in rats.

H Okubo, H Ishibashi, K Shibata, K Tsuda-Kawamura, T Yanase.   

Abstract

Distribution of uptake and catabolism of intravenously administered 125I-labeled rat alpha 2-macroglobulin(125I-alpha 2MG) were examined in normal, inflammatory, and tumor tissues of rats. Clearance of intravenously administered [125I]alpha 2MG from the circulation was rapid. Accumulation of this compound into inflammatory tissue was 2-3 times more extensive than in normal tissues. The accumulation into sarcoma tissue was much less. Radioactivity in TCA-PTA precipitates remained fairly constant for the first 12 h in inflammatory tissue and for the first 24 h in sarcoma. These patterns of accumulation were never observed in the normal tissues. As the kidney preferentially accumulated large amounts of [125I]alpha 2MG in the nondegraded form and its degradation products, the tissue may play a special role in the metabolism of alpha 2MG. Rapid clearance from the circulation and relatively small amounts of accumulation in tissues suggest that alpha 2MG may function as a protease inhibitor, mainly in the circulation rather than in the tissues.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6204941     DOI: 10.1007/bf00916092

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  24 in total

1.  Protein binding of pancreatic proteolytic enzymes.

Authors:  B J HAVERBACK; B DYCE; H F BUNDY; S K WIRTSCHAFTER; H A EDMONDSON
Journal:  J Clin Invest       Date:  1962-05       Impact factor: 14.808

2.  Uptake of fibrinogen and fibrinolytic enzymes by neoplastic tissue.

Authors:  N Back; R R Shields; G DeWitt; R H Branshaw; C M Ambrus
Journal:  J Natl Cancer Inst       Date:  1966-02       Impact factor: 13.506

3.  Effect of alpha 2-macroglobulin on the lymphocyte response.

Authors:  O Miyanaga; H Okubo; J Kudo; T Ikuta; Y Hirata
Journal:  Immunology       Date:  1982-10       Impact factor: 7.397

4.  Inhibition of polymorphonuclear leukocyte chemotaxis by alpha-macrofetoprotein, an acute-phase reactant of the rat.

Authors:  J van Gool; N C Ladiges; W Boers
Journal:  Inflammation       Date:  1982-06       Impact factor: 4.092

5.  Immunochemical detection of an acute-phase protein in rat serum.

Authors:  H E Weimer; D C Benjamin
Journal:  Am J Physiol       Date:  1965-10

6.  Rat alpha 1-acid glycoprotein: uptake by inflammatory and tumour tissues.

Authors:  K Shibata; H Okubo; H Ishibashi; K Tsuda-Kawamura; T Yanase
Journal:  Br J Exp Pathol       Date:  1978-12

7.  The interaction of alpha2-macroglobulin with proteinases. Binding and inhibition of mammalian collagenases and other metal proteinases.

Authors:  Z Werb; M C Burleigh; A J Barrett; P M Starkey
Journal:  Biochem J       Date:  1974-05       Impact factor: 3.857

8.  The interaction of alpha 2-macroglobulin with proteinases. Characteristics and specificity of the reaction, and a hypothesis concerning its molecular mechanism.

Authors:  A J Barrett; P M Starkey
Journal:  Biochem J       Date:  1973-08       Impact factor: 3.857

9.  Inhibition of malignant cell invasion in vitro by a proteinase inhibitor.

Authors:  A L Latner; E Longstaff; K Pradhan
Journal:  Br J Cancer       Date:  1973-06       Impact factor: 7.640

10.  alpha2-Macroglobulin on human vascular endothelium.

Authors:  C G Becker; P C Harpel
Journal:  J Exp Med       Date:  1976-07-01       Impact factor: 14.307

View more
  4 in total

1.  Detection of alpha 2-macroglobulin, alpha 1-protease inhibitor, and neutral protease-antiprotease complexes within liver granulomas of Schistosoma mansoni-infected mice.

Authors:  J L Truden; D L Boros
Journal:  Am J Pathol       Date:  1988-02       Impact factor: 4.307

2.  Recombinant latent transforming growth factor beta 1 has a longer plasma half-life in rats than active transforming growth factor beta 1, and a different tissue distribution.

Authors:  L M Wakefield; T S Winokur; R S Hollands; K Christopherson; A D Levinson; M B Sporn
Journal:  J Clin Invest       Date:  1990-12       Impact factor: 14.808

3.  Inhibition of beta2-microglobulin amyloid fibril formation by alpha2-macroglobulin.

Authors:  Daisaku Ozawa; Kazuhiro Hasegawa; Young-Ho Lee; Kazumasa Sakurai; Kotaro Yanagi; Tadakazu Ookoshi; Yuji Goto; Hironobu Naiki
Journal:  J Biol Chem       Date:  2011-01-07       Impact factor: 5.157

4.  Cryo-EM structures reveal the dynamic transformation of human alpha-2-macroglobulin working as a protease inhibitor.

Authors:  Xiaoxing Huang; Youwang Wang; Cong Yu; Hui Zhang; Qiang Ru; Xinxin Li; Kai Song; Min Zhou; Ping Zhu
Journal:  Sci China Life Sci       Date:  2022-06-28       Impact factor: 6.038

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.